These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 35791853)

  • 1. Barriers and Facilitators to Chronic Red Cell Transfusion Therapy in Pediatric Sickle Cell Anemia.
    Schlenz AM; Phillips SM; Mueller M; Melvin CL; Adams RJ; Kanter J
    J Pediatr Hematol Oncol Nurs; 2022; 39(4):209-220. PubMed ID: 35791853
    [No Abstract]   [Full Text] [Related]  

  • 2. Identified barriers and facilitators to stroke risk screening in children with sickle cell anemia: results from the DISPLACE consortium.
    Phillips SM; Schlenz AM; Mueller M; Melvin CL; Adams RJ; Kanter J
    Implement Sci Commun; 2021 Aug; 2(1):87. PubMed ID: 34376249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of red blood cell exchange, partial manual exchange, and simple transfusion concurrently with iron chelation therapy in reducing iron overload in chronically transfused sickle cell anemia patients.
    Fasano RM; Leong T; Kaushal M; Sagiv E; Luban NL; Meier ER
    Transfusion; 2016 Jul; 56(7):1707-15. PubMed ID: 26997031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pain and other non-neurological adverse events in children with sickle cell anemia and previous stroke who received hydroxyurea and phlebotomy or chronic transfusions and chelation: results from the SWiTCH clinical trial.
    Alvarez O; Yovetich NA; Scott JP; Owen W; Miller ST; Schultz W; Lockhart A; Aygun B; Flanagan J; Bonner M; Mueller BU; Ware RE;
    Am J Hematol; 2013 Nov; 88(11):932-8. PubMed ID: 23861242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stroke With Transfusions Changing to Hydroxyurea (SWiTCH): a phase III randomized clinical trial for treatment of children with sickle cell anemia, stroke, and iron overload.
    Ware RE; Schultz WH; Yovetich N; Mortier NA; Alvarez O; Hilliard L; Iyer RV; Miller ST; Rogers ZR; Scott JP; Waclawiw M; Helms RW
    Pediatr Blood Cancer; 2011 Dec; 57(6):1011-7. PubMed ID: 21826782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency of red cell alloimmunization in patients with sickle cell anemia in an Egyptian referral hospital.
    Aly R; El-sharnoby MR; Hagag AA
    Transfus Apher Sci; 2012 Dec; 47(3):253-7. PubMed ID: 22980915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of the DREPAGREFFE trial: A prospective controlled multicenter study evaluating the benefit of genoidentical hematopoietic stem cell transplantation over chronic transfusion in sickle cell anemia children detected to be at risk of stroke by transcranial Doppler (NCT 01340404).
    Chevret S; Verlhac S; Ducros-Miralles E; Dalle JH; de Latour RP; de Montalembert M; Benkerrou M; Pondarré C; Thuret I; Guitton C; Lesprit E; Etienne-Julan M; Elana G; Vannier JP; Lutz P; Neven B; Galambrun C; Paillard C; Runel C; Jubert C; Arnaud C; Kamdem A; Brousse V; Missud F; Petras M; Doumdo-Divialle L; Berger C; Fréard F; Taieb O; Drain E; Elmaleh M; Vasile M; Khelif Y; Bernaudin M; Chadebech P; Pirenne F; Socié G; Bernaudin F
    Contemp Clin Trials; 2017 Nov; 62():91-104. PubMed ID: 28821470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Red cell alloimmunization in multi-transfused patients with sickle cell anemia in Benin City, Nigeria.
    Ugwu NI; Awodu OA; Bazuaye GN; Okoye AE
    Niger J Clin Pract; 2015; 18(4):522-6. PubMed ID: 25966726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Red cell transfusion and alloimmunization in sickle cell disease.
    Linder GE; Chou ST
    Haematologica; 2021 Jul; 106(7):1805-1815. PubMed ID: 33792218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transfusional iron overload in children with sickle cell anemia on chronic transfusion therapy for secondary stroke prevention.
    Kwiatkowski JL; Cohen AR; Garro J; Alvarez O; Nagasubramanian R; Sarnaik S; Thompson A; Woods GM; Schultz W; Mortier N; Lane P; Mueller B; Yovetich N; Ware RE;
    Am J Hematol; 2012 Feb; 87(2):221-3. PubMed ID: 22120913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving access to healthcare for paediatric sickle cell disease patients: a qualitative study on healthcare professionals' views.
    Houwing ME; Buddenbaum M; Verheul TCJ; de Pagter APJ; Philipsen JNJ; Hazelzet JA; Cnossen MH
    BMC Health Serv Res; 2021 Mar; 21(1):229. PubMed ID: 33712013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease.
    Estcourt LJ; Kohli R; Hopewell S; Trivella M; Wang WC
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD003146. PubMed ID: 32716555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Practice patterns for neuroimaging and transfusion therapy for management of neurologic complications in sickle cell anemia: DISPLACE consortium.
    Phillips S; Schlenz AM; Mueller M; Melvin C; Adams RJ; Kanter J;
    Pediatr Blood Cancer; 2020 Nov; 67(11):e28569. PubMed ID: 32894002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Red blood cell transfusion to treat or prevent complications in sickle cell disease: an overview of Cochrane reviews.
    Fortin PM; Hopewell S; Estcourt LJ
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD012082. PubMed ID: 30067867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease.
    Wang WC; Dwan K
    Cochrane Database Syst Rev; 2013 Nov; (11):CD003146. PubMed ID: 24226646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of Patients with Sickle Cell Disease Using Transfusion Therapy: Guidelines and Complications.
    Chou ST; Fasano RM
    Hematol Oncol Clin North Am; 2016 Jun; 30(3):591-608. PubMed ID: 27112998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient and family experience with chronic transfusion therapy for sickle cell disease: A qualitative study.
    Hawkins LM; Sinha CB; Ross D; Yee MEM; Quarmyne MO; Krishnamurti L; Bakshi N
    BMC Pediatr; 2020 Apr; 20(1):172. PubMed ID: 32305060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health-related Quality of Life in Children With Sickle Cell Disease Undergoing Chronic Red Cell Transfusion Therapy.
    Maxwell SL; Schlenz AM; Kanter J
    J Pediatr Hematol Oncol; 2019 May; 41(4):307-312. PubMed ID: 31026251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal MRI and Ferritin Monitoring of Iron Overload in Chronically Transfused and Chelated Children With Sickle Cell Anemia and Thalassemia Major.
    Aubart M; Ou P; Elie C; Canniffe C; Kutty S; Delos V; Graffigne C; de Montalembert M; Brousse V
    J Pediatr Hematol Oncol; 2016 Oct; 38(7):497-502. PubMed ID: 27548334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfusion and Cellular Therapy in Pediatric Sickle Cell Disease.
    Zheng Y; Chou ST
    Clin Lab Med; 2021 Mar; 41(1):101-119. PubMed ID: 33494879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.